BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33805778)

  • 1. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation.
    Chatterjee P; Tegg M; Pedrini S; Fagan AM; Xiong C; Singh AK; Taddei K; Gardener S; Masters CL; Schofield PR; Multhaup G; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; van Buchem MA; Stoops E; Vanderstichele H; Teunissen CE; Hankey GJ; Wermer MJH; Sohrabi HR; Martins RN; The Dominantly Inherited Alzheimer Network
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations.
    Chatterjee P; Fagan AM; Xiong C; McKay M; Bhatnagar A; Wu Y; Singh AK; Taddei K; Martins I; Gardener SL; Molloy MP; Multhaup G; Masters CL; Schofield PR; Benzinger TLS; Morris JC; Bateman RJ; Greenberg SM; Wermer MJH; van Buchem MA; Sohrabi HR; Martins RN;
    J Alzheimers Dis; 2021; 79(2):895-903. PubMed ID: 33361604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary cerebral hemorrhage with amyloidosis-Dutch type.
    Maat-Schieman M; Roos R; van Duinen S
    Neuropathology; 2005 Dec; 25(4):288-97. PubMed ID: 16382777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Approaches to Diffusion Magnetic Resonance Imaging in Hereditary Cerebral Amyloid Angiopathy Mutation Carriers.
    Schouten TM; de Vos F; van Rooden S; Bouts MJRJ; van Opstal AM; Feis RA; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; de Rooij M; Rombouts SARB; van der Grond J
    J Am Heart Assoc; 2019 Feb; 8(3):e011288. PubMed ID: 30717612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral amyloid angiopathy-linked β-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen.
    Cajamarca SA; Norris EH; van der Weerd L; Strickland S; Ahn HJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14482-14492. PubMed ID: 32518112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
    de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
    Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration.
    Bornebroek M; De Jonghe C; Haan J; Kumar-Singh S; Younkin S; Roos R; Van Broeckhoven C
    Neurobiol Dis; 2003 Dec; 14(3):619-23. PubMed ID: 14678776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers.
    Schultz AP; Kloet RW; Sohrabi HR; van der Weerd L; van Rooden S; Wermer MJH; Moursel LG; Yaqub M; van Berckel BNM; Chatterjee P; Gardener SL; Taddei K; Fagan AM; Benzinger TL; Morris JC; Sperling R; Johnson K; Bateman RJ; ; Gurol ME; van Buchem MA; Martins R; Chhatwal JP; Greenberg SM
    Ann Neurol; 2019 Oct; 86(4):616-625. PubMed ID: 31361916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Progression of Magnetic Resonance Imaging Markers and Cognition in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    van Dijk SE; van der Grond J; Lak J; van den Berg-Huysmans A; Labadie G; Terwindt GM; Wermer MJH; Gurol ME; van Buchem MA; Greenberg SM; van Rooden S
    Stroke; 2022 Jun; 53(6):2006-2015. PubMed ID: 35360926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis.
    De Meyer S; Schaeverbeke JM; Verberk IMW; Gille B; De Schaepdryver M; Luckett ES; Gabel S; Bruffaerts R; Mauroo K; Thijssen EH; Stoops E; Vanderstichele HM; Teunissen CE; Vandenberghe R; Poesen K
    Alzheimers Res Ther; 2020 Dec; 12(1):162. PubMed ID: 33278904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor.
    Van Nostrand WE; Melchor JP; Romanov G; Zeigler K; Davis J
    Ann N Y Acad Sci; 2002 Nov; 977():258-65. PubMed ID: 12480759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy.
    Obici L; Demarchi A; de Rosa G; Bellotti V; Marciano S; Donadei S; Arbustini E; Palladini G; Diegoli M; Genovese E; Ferrari G; Coverlizza S; Merlini G
    Ann Neurol; 2005 Oct; 58(4):639-44. PubMed ID: 16178030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial cerebral amyloid angiopathy related to stroke and dementia.
    Frangione B; Révész T; Vidal R; Holton J; Lashley T; Houlden H; Wood N; Rostagno A; Plant G; Ghiso J
    Amyloid; 2001 Jul; 8 Suppl 1():36-42. PubMed ID: 11676288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.
    van Opstal AM; van Rooden S; van Harten T; Ghariq E; Labadie G; Fotiadis P; Gurol ME; Terwindt GM; Wermer MJH; van Buchem MA; Greenberg SM; van der Grond J
    Lancet Neurol; 2017 Feb; 16(2):115-122. PubMed ID: 27989553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.
    van Etten ES; Verbeek MM; van der Grond J; Zielman R; van Rooden S; van Zwet EW; van Opstal AM; Haan J; Greenberg SM; van Buchem MA; Wermer MJ; Terwindt GM
    Neurology; 2017 Jan; 88(2):169-176. PubMed ID: 27903811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke.
    Hernandez-Guillamon M; Delgado P; Penalba A; Rodriguez-Luna D; Molina CA; Rovira A; Alvarez-Sabin J; Boada M; Montaner J
    Neurodegener Dis; 2012; 10(1-4):320-3. PubMed ID: 22261638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    Piccarducci R; Caselli MC; Zappelli E; Ulivi L; Daniele S; Siciliano G; Ceravolo R; Mancuso M; Baldacci F; Martini C
    J Alzheimers Dis; 2022; 89(3):1039-1049. PubMed ID: 35964181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type.
    Kamp JA; Moursel LG; Haan J; Terwindt GM; Lesnik Oberstein SA; van Duinen SG; van Roon-Mom WM
    Rev Neurosci; 2014; 25(5):641-51. PubMed ID: 24870607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine With Aura as Early Disease Marker in Hereditary Dutch-Type Cerebral Amyloid Angiopathy.
    Koemans EA; Voigt S; Rasing I; van Etten ES; van Zwet EW; van Walderveen MAA; Wermer MJH; Terwindt GM
    Stroke; 2020 Apr; 51(4):1094-1099. PubMed ID: 32114932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.